1-8 of 8
Mathieu Monconduit
Close
Save search
Sort by
Journal Articles

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Free
Clinical Trials & Observations
Hervé Avet-Loiseau, Michel Attal, Philippe Moreau, Catherine Charbonnel, Frédéric Garban, Cyrille Hulin, Serge Leyvraz, Mauricette Michallet, Ibrahim Yakoub-Agha, Laurent Garderet, Gérald Marit, Lucienne Michaux, Laurent Voillat, Marc Renaud, Bernard Grosbois, Gaelle Guillerm, Lotfi Benboubker, Mathieu Monconduit, Catherine Thieblemont, Philippe Casassus, Denis Caillot, Anne-Marie Stoppa, Jean-Jacques Sotto, Marc Wetterwald, Charles Dumontet, Jean-Gabriel Fuzibet, Isabelle Azais, Véronique Dorvaux, Marc Zandecki, Régis Bataille, Stéphane Minvielle, Jean-Luc Harousseau, Thierry Facon, Claire Mathiot
Journal: Blood
Blood (2007) 109 (8): 3489–3495.
https://doi.org/10.1182/blood-2006-08-040410
Published: 2007
Includes: Supplemental data
Journal Articles

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

Free
Clinical Trials & Observations
Michel Attal, Jean-Luc Harousseau, Serge Leyvraz, Chantal Doyen, Cyrille Hulin, Lofti Benboubker, Ibrahim Yakoub Agha, Jean-Henri Bourhis, Laurent Garderet, Brigitte Pegourie, Charles Dumontet, Marc Renaud, Laurent Voillat, Christian Berthou, Gerald Marit, Mathieu Monconduit, Denis Caillot, Bernard Grobois, Herve Avet-Loiseau, Philippe Moreau, Thierry Facon, for the Inter-Groupe Francophone du Myélome (IFM)
Journal: Blood
Blood (2006) 108 (10): 3289–3294.
https://doi.org/10.1182/blood-2006-05-022962
Published: 2006
Journal Articles

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Free
Clinical Trials & Observations
Thierry Facon, Jean-Yves Mary, Brigitte Pégourie, Michel Attal, Marc Renaud, Alain Sadoun, Laurent Voillat, Véronique Dorvaux, Cyrille Hulin, Gérard Lepeu, Jean-Luc Harousseau, Jean-Paul Eschard, Augustin Ferrant, Michel Blanc, Frédéric Maloisel, Hubert Orfeuvre, Jean-François Rossi, Isabelle Azaïs, Mathieu Monconduit, Philippe Collet, Bruno Anglaret, Ibrahim Yakoub-Agha, Marc Wetterwald, Houchingue Eghbali, Marie-Christine Vekemans, Hervé Maisonneuve, Jacques Troncy, Bernard Grosbois, Chantal Doyen, Antoine Thyss, Jérome Jaubert, Philippe Casassus, Béatrice Thielemans, Régis Bataille, for the Intergroupe Francophone du Myélome (IFM) group
Journal: Blood
Blood (2006) 107 (4): 1292–1298.
https://doi.org/10.1182/blood-2005-04-1588
Published: 2006
Journal Articles

Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol

Free
Clinical Trials & Observations
Philippe Moreau, Cyrille Hullin, Frédéric Garban, Ibrahim Yakoub-Agha, Lotfi Benboubker, Michel Attal, Gérald Marit, Jean-Gabriel Fuzibet, Chantal Doyen, Laurent Voillat, Christian Berthou, Nicolas Ketterer, Philippe Casassus, Mathieu Monconduit, Mauricette Michallet, Albert Najman, Jean-Jacques Sotto, Régis Bataille, Jean-Luc Harousseau, for the Intergroupe Francophone du Myélome group
Journal: Blood
Blood (2006) 107 (1): 397–403.
https://doi.org/10.1182/blood-2005-06-2573
Published: 2006
Journal Articles

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma: Final Analysis of a Prospective Randomized Study of the “Intergroupe Francophone du Myelome”.

Free
Michel Attal, Jean-Luc Harousseau, Serge Leyvraz, Chantal Doyen, Cyrille Hulin, Lofti Benboubker, Ibrahim Yakoub Agha, Jean-Henri Bourhis, Laurent Garderet, Jean-Jacques Sotto, Mauricette Michallet, Marc Renaud, Laurent Voillat, Christian Berthou, Gerald Marit, Mathieu Monconduit, Charles Dumonté, Denis Caillot, Claire Mathiot, Hervé Avet-Loiseau, for the IFM
Journal: Blood
Blood (2005) 106 (11): 1148.
https://doi.org/10.1182/blood.V106.11.1148.1148
Published: 2005
Journal Articles

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma : First Analysis of a Prospective Randomized Study of the Intergroupe Francophone du Myelome (IFM 99 02).

Free
Michel Attal, MD, Jean-Luc Harousseau, MD, Serge Leyvraz, MD, Chantal Doyen, MD, Cyrille Hulin, MD, Lofti Benboubker, MD, Thierry Facon, MD, Jean-Henri Bourhis, MD, Laurent Garderet, MD, Jean-Jacques Sotto, MD, Mauricette Michallet, MD, Marc Renaud, MD, Laurent Voillat, MD, Christian Berthou, MD, Gerald Marrit, MD, Mathieu Monconduit, MD, Bertrand Coiffier, MD, Denis Caillot, MD
Journal: Blood
Blood (2004) 104 (11): 535.
https://doi.org/10.1182/blood.V104.11.535.535
Published: 2004
Journal Articles

Randomized Clinical Trial Comparing Melphalan-Prednisone (MP), MP-Thalidomide (MP-THAL) and High-Dose Therapy Using Melphalan 100 MG/M 2 (MEL100) for Newly Diagnosed Myeloma Patients Aged 65–75 Years. Interim Analysis of the IFM 99-06 Trial on 350 Patients.

Free
Thierry Facon, Jean Yves Mary, Cyril Hulin, Lofti Benboubker, Michel Attal, Jean Luc Harousseau, Brigitte Pegourie, Marc Renaud, Gaelle Guillerm, Laurent Voillat, Carine Chaleteix, Jacques Troncy, Mathieu Monconduit, Philippe Casassus, Herve Maisonneuve, Veronique Dorvaux, Jerome Jaubert, Mamoun Dib, Chantal Doyen
Journal: Blood
Blood (2004) 104 (11): 206.
https://doi.org/10.1182/blood.V104.11.206.206
Published: 2004
Journal Articles

Prognostic factors in Waldenström macroglobulinemia: a report on 232 patients with the description of a new scoring system and its validation on 253 other patients

Free
Clinical Trials & Observations
Pierre Morel, Mathieu Monconduit, Dominique Jacomy, Pascal Lenain, Bernard Grosbois, Christine Bateli, Thierry Facon, Isabelle Dervite, Francis Bauters, Albert Najman, Aimery de Gramont, Eric Wattel
Journal: Blood
Blood (2000) 96 (3): 852–858.
https://doi.org/10.1182/blood.V96.3.852
Published: 2000